A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer

Cancer

Volumn 117, Issue 22, 2011, Pages 5172-5181

  Liu, Li ^a   Wu, Jing ^a   Wu, Chen ^b   Wang, Ying ^a   Zhong, Rong ^a   Zhang, Xinyu ^c   Tan, Wen ^b   Nie, Shaofa ^a   Miao, Xiaoping ^a   Lin, Dongxin ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CANCER HOSPITAL   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

association study; lung cancer; matrix metalloproteinase 1; single nucleotide polymorphism; susceptibility

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; ADVANCED CANCER; ARTICLE; ASIAN; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CAUCASIAN; CHINESE; CONTROLLED STUDY; EARLY CANCER; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 1; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK;

EID: 80555155587     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26154     Document Type: Article

References (60)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008; 58: 71-96.
2. Boyle P, Levin B, eds. World Cancer Report 2008. Lyon, France: IARC Press; 2008.
3. Li LD, Lu FZ, Zhang SW, et al. Analysis of variation trend and short term detection of Chinese malignant tumor mortality during twenty years. Chin J Oncol. 1997; 19: 3-9.
4. Yang L, Parkin DM, Li LD, Chen YD, Bray F,. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer. 2004; 90: 2157-2166. (Pubitemid 38869723)
5. Liao ML, Chen ZW, Zheng Y, et al. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations]. Zhonghua Yi Xue Za Zhi. 2007; 87: 1876-1880. (Pubitemid 47527510)
6. Park JY, Matsuo K, Suzuki T, et al. Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 (ALDH2) null allele in a Japanese population. Carcinogenesis. 2010; 31: 660-665.
7. Galvan A, Falvella FS, Frullanti E, et al. Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer. Carcinogenesis. 2010; 31: 462-465.
8. Benhamou S, Sarasin A,. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol. 2005; 161: 1-14. (Pubitemid 40053274)
9. Zhang X, Miao X, Guo Y, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat. 2006; 27: 110-117. (Pubitemid 43042973)
10. Egeblad M, Werb Z,. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2: 161-174. (Pubitemid 37328786)
11. Sternlicht MD, Werb Z,. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17: 463-516. (Pubitemid 33096184)
12. Gorelik L, Flavell RA,. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med. 2001; 7: 1118-1122. (Pubitemid 33010019)
13. Kataoka H, Uchino H, Iwamura T, Seiki M, Nabeshima K, Koono M,. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am J Pathol. 1999; 154: 457-468. (Pubitemid 29094096)
14. Brinckerhoff CE, Rutter JL, Benbow U,. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000; 6: 4823-4830. (Pubitemid 32110426)
15. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE,. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr. 1996; 6: 391-411. (Pubitemid 26422410)
16. Noh EM, Kim JS, Hur H, et al. Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts. Rheumatology (Oxford). 2009; 48: 45-48.
17. Lehrke M, Greif M, Broedl UC, et al. MMP-1 serum levels predict coronary atherosclerosis in humans [serial online]. Cardiovasc Diabetol. 2009; 8: 50.
18. Buergy D, Weber T, Maurer GD, et al. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Int J Cancer. 2009; 125: 894-901.
19. Kessenbrock K, Plaks V, Werb Z,. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141: 52-67.
20. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998; 58: 5321-5325. (Pubitemid 28551108)
21. Ghilardi G, Biondi ML, Mangoni J, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res. 2001; 7: 2344-2346. (Pubitemid 32751634)
22. Hughes S, Agbaje O, Bowen RL, et al. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res. 2007; 13: 6673-6680. (Pubitemid 350206803)
23. Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V,. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int. 2008; 101: 503-507. (Pubitemid 351160936)
24. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X,. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001; 61: 7825-7829. (Pubitemid 33049371)
25. Su L, Zhou W, Asomaning K, et al. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis. 2006; 27: 1024-1029.
26. Fang S, Jin X, Wang R, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis. 2005; 26: 481-486. (Pubitemid 40246571)
27. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons; 1997.
28. World Health Organization. International Histological Classification of Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 1988.
29. Miao X, Xing D, Tan W, Qi J, Lu W, Lin D,. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2002; 11: 1454-1458. (Pubitemid 35340384)
30. Ye S, Dhillon S, Turner SJ, et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 2001; 61: 1296-1298. (Pubitemid 34292545)
31. Miao X, Sun T, Wang Y, Zhang X, Tan W, Lin D,. Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma. Cancer Res. 2004; 64: 2680-2683. (Pubitemid 38500601)
32. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188. (Pubitemid 17189972)
33. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22: 719-748.
34. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
35. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. (Pubitemid 27387172)
36. Pulukuri SM, Rao JS,. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol. 2008; 32: 757-765. (Pubitemid 351780586)
37. Sunami E, Tsuno N, Osada T, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 2000; 5: 108-114. (Pubitemid 30238230)
38. Hao B, Miao X, Li Y, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006; 25: 3613-3620. (Pubitemid 43901683)
39. Miura S, Ohno I, Suzuki J, et al. Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by beta-adrenergic stimulation in rats. J Cardiovasc Pharmacol. 2003; 42: 174-181. (Pubitemid 36899668)
40. Manicone AM, McGuire JK,. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 2008; 19: 34-41. (Pubitemid 350235986)
41. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE,. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med. 1996; 2: 461-462. (Pubitemid 26191919)
42. Eck SM, Hoopes PJ, Petrella BL, Coon CI, Brinckerhoff CE,. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat. 2009; 116: 79-90.
43. Sauter W, Rosenberger A, Beckmann L, et al. Matrix metalloproteinase 1 (MMP1) is associated with early onset lung cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1127-1135.
44. Westermarck J, Seth A, Kahari VM,. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene. 1997; 14: 2651-2660. (Pubitemid 27283104)
45. Tower GB, Coon CC, Benbow U, Vincenti MP, Brinckerhoff CE,. Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. Biochim Biophys Acta. 2002; 1586: 265-274. (Pubitemid 34457921)
46. Park YH, Jung HH, Ahn JS, Im YH,. Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. Biochem Biophys Res Commun. 2008; 377: 389-394.
47. Li J, Ghio AJ, Cho SH, Brinckerhoff CE, Simon SA, Liedtke W,. Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ Health Perspect. 2009; 117: 400-409.
48. Bradbury PA, Zhai R, Hopkins J, et al. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis. 2009; 30: 793-798.
49. Zhang WQ, Lin H, Zhou YA, Wang YJ, Cheng QS,. [Association of MMP1 -1607(1Gâ2G) single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23: 313-315. (Pubitemid 43937915)
50. Cheng XL,. [Correlation of single nucleotide polymorphism in the matrix metalloproteinase-1 gene promoter (-1607)1G/2G with risk of lung cancer]. J Shanxi Med University. 2007; 9: 777-779.
51. Iida J, McCarthy JB,. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta. Melanoma Res. 2007; 17: 205-213. (Pubitemid 47067078)
52. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A,. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 2005; 120: 303-313. (Pubitemid 40222426)
53. Lu X, Wang Q, Hu G, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009; 23: 1882-1894.
54. Blackburn JS, Brinckerhoff CE,. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol. 2008; 173: 1736-1746.
55. Arribas J,. Matrix metalloproteases and tumor invasion. N Engl J Med. 2005; 352: 2020-2021.
56. Cabibi D, Calascibetta A, Aragona F, Martorana A, Campione M, Sanguedolce R,. Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma. Anticancer Res. 2009; 29: 4417-4422.
57. Li M, Xiao T, Zhang Y, et al. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer. 2010; 69: 341-347.
58. Mathias RA, Wang B, Ji H, et al. Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. J Proteome Res. 2009; 8: 2827-2283.
59. Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE,. RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res. 2007; 67: 10849-10858. (Pubitemid 350145914)
60. Przybylowska K, Zielinska J, Zadrozny M, et al. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymph node metastasis in breast cancer. J Exp Clin Cancer Res. 2004; 23: 121-125. (Pubitemid 38552606)